Category: Below Bottom Bollinger Band

Chart Scan – Jan 02, 2023

Chart Scan – Jan 02, 2023

ECOR – electroCore, Inc.

HIMX – Himax Technologies Inc.

STAB – Statera Biopharma, Inc.

TIGR – UP Fintech Holding Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 30, 2022

Chart Scan – Dec 30, 2022

ECOR – electroCore, Inc.

HIMX – Himax Technologies Inc.

STAB – Statera Biopharma, Inc.

TIGR – UP Fintech Holding Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 29, 2022

Chart Scan – Dec 29, 2022

FSTX – F-star Therapeutics, Inc.

HEPS – D-MARKET Electronic Services & Trading

JSPR – Jasper Therapeutics, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 28, 2022

Chart Scan – Dec 28, 2022

BBIG – Vinco Ventures, Inc.

BIGC – BigCommerce Holdings Inc.

CIFR – Cipher Mining Inc.

GT – Goodyear Tire & Rubber Co.

HLBZ – Helbiz, Inc.

NERV – Minerva Neurosciences, Inc.

NUZE – Nuzee Inc.

NYMT – New York Mortgage Trust Inc.

TALK – Talkspace Inc.

TUEM – Tuesday Morning Corp.

VWE – Vintage Wine Estates, Inc.

WW – Weight Watchers Intl Inc.

XM – Qualtrics International Inc.

YELL – Yellow Corporation

YMM – Full Truck Alliance Co Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 27, 2022

Chart Scan – Dec 27, 2022

ABSI – Absci Corp.

ACCD – Accolade Inc.

ACVA – ACV Auctions Inc.

ADVM – Adverum Biotechnologies, Inc.

ATER – Aterian, Inc.

AUPH – Aurinia Pharmaceuticals Inc.

AYTU – Aytu BioScience, Inc.

BITF – Bitfarms Ltd.

BLDE – Blade Air Mobility Inc.

BLUE – Bluebird Bio Inc.

BNGO – Bionano Genomics, Inc.

CAN – Canaan Inc

CEMI – Chembio Diagnostics Inc.

CERS – Cerus Corp.

CHRS – Coherus BioSciences Inc.

CIDM – Cinedigm Digital Cinema Corp.

CMRX – Chimerix, Inc.

CVAC – CureVac B.V.

CYXT – Cyxtera Technologies, Inc.

EDIT – Editas Medicine, Inc.

EVGO – EVgo Inc.

GMTX – Aslet Gemini Therapeutics Inc.

GOEV – Canoo Inc.

HIMX – Himax Technologies Inc.

HIVE – HIVE Blockchain Technologies Ltd.

HRTX – Heron Therapeutics, Inc.

HYZN – Hyzon Motors Inc.

IBRX – ImmunityBio, Inc.

IMAB – I-Mab

INO – Inovio Pharmaceuticals, Inc.

JAGX – Jaguar Health, Inc.

LAZR – Luminar Technologies, Inc.

MNMD – Mind Medicine Inc.

NCMI – National CineMedia Inc.

OP – OceanPal Inc.

ORGN – Origin Materials Inc.

PAVM – PAVmed, Inc.

PGEN – Precigen, Inc.

PIRS – Pieris Pharmaceuticals Inc.

PTRA – Proterra Inc.

RKLB – Rocket Lab USA, Inc.

SABR – Sabre Corp.

SHCR – Sharecare Inc.

SIEN – Sientra, Inc.

SUNW – Sunworks, Inc.

TCRT – Alaunos Therapeutics, Inc.

TSLL – Direxion Daily TSLA Bull 1.5X Shares

VUZI – Vuzix Corp.

XOS – Xos, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 26, 2022

Chart Scan – Dec 26, 2022

AMTI – Applied Molecular Transport Inc.

ATAI – ATAI Life Sciences N.V.

BBIO – BridgeBio Pharma Inc.

BLDP – Ballard Power Systems, Inc.

CTXR – Citius Pharmaceuticals Inc.

GTHX – G1 Therapeutics, Inc

HOFV – Hall of Fame Resort & Entertainment Company

MREO – Mereo BioPharma Group Plc

NEO – NeoGenomics, Inc.

NNOX – Nano X Imaging Ltd.

NRBO – NeuroBo Pharmaceuticals Inc

OCGN – Ocugen Inc.

PTON – Peloton Interactive Inc.

SGMO – Sangamo Therapeutics, Inc.

STAB – Statera Biopharma, Inc.

TENX – Tenax Therapeutics, Inc.

VXRT – Vaxart, Inc.

YGMZ – MingZhu Logistics Holdings Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 23, 2022

Chart Scan – Dec 23, 2022

AMTI – Applied Molecular Transport Inc.

ATAI – ATAI Life Sciences N.V.

BBIO – BridgeBio Pharma Inc.

BLDP – Ballard Power Systems, Inc.

CTXR – Citius Pharmaceuticals Inc.

GTHX – G1 Therapeutics, Inc

HOFV – Hall of Fame Resort & Entertainment Company

MREO – Mereo BioPharma Group Plc

NEO – NeoGenomics, Inc.

NNOX – Nano X Imaging Ltd.

NRBO – NeuroBo Pharmaceuticals Inc

OCGN – Ocugen Inc.

PTON – Peloton Interactive Inc.

SGMO – Sangamo Therapeutics, Inc.

STAB – Statera Biopharma, Inc.

TENX – Tenax Therapeutics, Inc.

VXRT – Vaxart, Inc.

YGMZ – MingZhu Logistics Holdings Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 22, 2022

Chart Scan – Dec 22, 2022

ACMR – ACM Research, Inc.

DATS – DatChat Inc.

DRUG – Bright Minds Biosciences Inc.

DTIL – Precision BioSciences Inc.

EVLV – Evolv Technologies Holdings, Inc.

HIVE – HIVE Blockchain Technologies Ltd.

LPRO – Open Lending Corp

LWLG – Lightwave Logic, Inc.

LZ – LegalZoom.com Inc.

MAPS – WM Technology, Inc.

NKTR – Nektar Therapeutics

NXTC – NextCure, Inc.

OP – OceanPal Inc.

ORGN – Origin Materials Inc.

RDFN – Redfin Corp

REAL – RealReal Inc.

SELB – Selecta Biosciences, Inc.

SOLO – Electrameccanica Vehicles Corp.

TSLL – Direxion Daily TSLA Bull 1.5X Shares

TWOU – 2U, Inc.

VIEW – View, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 21, 2022

Chart Scan – Dec 21, 2022

CDXS – Codexis Inc.

EMKR – EMCORE Corp.

GLDD – Great Lakes Dredge & Dock Corp.

IDEX – Ideanomics, Inc.

LFMD – LifeMD, Inc.

LGHL – Lion Group Holding Ltd

LIDR – AEye, Inc.

MNTV – Momentive Global Inc.

OBLG – Oblong, Inc

OCGN – Ocugen Inc.

PLBY – PLBY Group, Inc.

RRGB – Red Robin Gourmet Burgers Inc.

RSLS – ReShape Lifesciences, Inc.

SWVL – Swvl Holdings Corp

TSVT – 2seventy bio Inc.

WNW – Wunong Net Technology Co Ltd.

ZIMV – ZimVie Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Dec 20, 2022

Chart Scan – Dec 20, 2022

ADMP – Adamis Pharmaceuticals Corp.

ADVM – Adverum Biotechnologies, Inc.

ASTR – Astra Space Inc.

BIRD – Allbirds Inc.

BLDP – Ballard Power Systems, Inc.

BLU – BELLUS Health, Inc.

CACO – Caravelle International Group

CVT – Cvent Holding Corp.

FCEL – FuelCell Energy, Inc.

HGEN – Humanigen, Inc.

HIMX – Himax Technologies Inc.

ILPT – Industrial Logistics Properties Trust

OP – OceanPal Inc.

OXLC – Oxford Lane Capital Corp.

RKLB – Rocket Lab USA, Inc.

SFT – Shift Technologies, Inc.

SHC – Sotera Health Co

STRO – Sutro Biopharma Inc.

TSLL – Direxion Daily TSLA Bull 1.5X Shares

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.